Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 2)*
|
SS Innovations International, Inc. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
05453U203 (CUSIP Number) |
03/31/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 05453U203 |
| 1 | Names of Reporting Persons
Sudhir Srivastava, M.D. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
117,324,445.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
60.60 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: Consists of (a) 112,926,514 shares of Common Stock of the Company held by Sushruta PVT LTD; (b) 32,000 shares of Common Stock of the Company held by Dr. Srivastava; and (c) Options held by Dr. Srivastava to purchase 4,364,931 shares of Common Stock of the Company. Dr. Srivastava has a 100% interest in Sushruta PVT LTD. Percentage in Row 11 is calculated based on 193,603,970 shares of common stock outstanding as of May 13, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
SCHEDULE 13G
|
| CUSIP No. | 05453U203 |
| 1 | Names of Reporting Persons
Sushruta PVT LTD | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
BAHAMAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
112,926,514.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
58.33 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
OO |
Comment for Type of Reporting Person: Row 5 and Row 7 consists of 112,926,514 shares of Common Stock of the Company held by Sushruta PVT LTD. Percentage in Row 11 is calculated based on 193,603,970 shares of common stock outstanding as of May 13, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
SS Innovations International, Inc. | |
| (b) | Address of issuer's principal executive offices:
1600 SE 15th Street, #512 Fort Lauderdale, FL 33316 | |
| Item 2. | ||
| (a) | Name of person filing:
(1) Sudhir Srivastava, M.D. (2) Sushruta PVT LTD | |
| (b) | Address or principal business office or, if none, residence:
The address for Sudhir Srivastava, M.D., Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD is as follows: 1600 SE 15th Street, #512 Fort Lauderdale, FL 33316 | |
| (c) | Citizenship:
Sudhir Srivastava, M.D. - USA Sushruta PVT LTD - Commonwealth of the Bahamas | |
| (d) | Title of class of securities:
Common Stock | |
| (e) | CUSIP No.:
05453U203 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
(1) Sudhir Srivastava, M.D. - 117,324,445 (2) Sushruta PVT LTD - 112,926,514 | |
| (b) | Percent of class:
(1) Sudhir Srivastava, M.D. - 60.60% (2) Sushruta PVT LTD - 58.33%. All calculations of percentage ownership herein are based upon an aggregate of 193,603,970 shares of common stock outstanding as of May 13, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed with the Securities and Exchange Commission on May 14, 2025. %
| |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
(1) Sudhir Srivastava, M.D. - 117,324,445 (2) Sushruta PVT LTD - 112,926,514 | ||
| (ii) Shared power to vote or to direct the vote:
(1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0 | ||
| (iii) Sole power to dispose or to direct the disposition of:
(1) Sudhir Srivastava, M.D. - 117,324,445 (2) Sushruta PVT LTD - 112,926,514 | ||
| (iv) Shared power to dispose or to direct the disposition of:
(1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
The shares of common stock referenced in Item 4, Section (a) above include shares held of record by Sushruta PVT LTD. Dr. Srivastava owns a 100% beneficial interest in Sushruta PVT LTD. | ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
Exhibit Information
|
JOINT FILING AGREEMENT |